Oral Presentation — Publications
Resources and insights tagged oral presentation from Headwater.
Publications
36
Total Publications
36
Oral Presentation
2024 · Oral Presentation · Yes · Methods/Pharmacoepi
Making the Case for Negative Control Outcome Studies in a Real-World Evidence Setting
Read more →2024 · Oral Presentation · Yes · Methods/Pharmacoepi
Seeing Eye to Eye: Enhancing Inter-Team Communication for Reproducible Real-World Evidence
Read more →2024 · Oral Presentation · Yes · Methods/Pharmacoepi
Comparing causal estimands from a sequential nested trial emulation with a treatment decision design to a conventional single point randomized trial: A simulation study
Read more →2023 · Oral Presentation · Yes · Methods/Pharmacoepi
Methods and New Approaches in Pragmatic Trials
Read more →2023 · Oral Presentation · Yes · Methods/Pharmacoepi
Characterizing the Distribution of Multiple Negative Control Outcome Risk Differences
Read more →2023 · Oral Presentation · Yes · Methods/Pharmacoepi
Orthogonalized Regression for Causal Inference: A Pharmacoepidemiologist's Dream?
Read more →2023 · Oral Presentation · Yes · Methods/Pharmacoepi
An Analytic Method to Weight Longitudinal Treatment Patterns for Visualization with Sankey Diagrams
Read more →2023 · Oral Presentation · Botswana Harvard AIDS Institute Partnership · Methods/Pharmacoepi
Methods and New Approaches in Pragmatic Trials Case Study: Botswana Combination Prevention Project
Read more →2022 · Oral Presentation · Yes · Methods/Pharmacoepi
In-Hospital Treatment Patterns Among Patients Hospitalized with COVID-19 in the United States
Read more →2022 · Oral Presentation · Yes · Methods/Pharmacoepi
Discharged Where? The Importance of Understanding Discharge Dispositions When Estimating In-Hospital Mortality
Read more →2022 · Oral Presentation · Amgen Inc. · Methods/Pharmacoepi
Fracture Risk Estimation in Post-menopausal Women: A Comparison of Machine Learning Methods and Software Systems
Read more →2022 · Oral Presentation · Yes · Methods/Pharmacoepi
Risk Factors for Mortality and Intensive Care Requirements Among Pediatric Patients Hospitalized with COVID-19 in the United States
Read more →2022 · Oral Presentation · Yes · Methods/Pharmacoepi
The Effect of Remdesivir for The Treatment of COVID-19 on Mortality Among Hospitalized Patients
Read more →2022 · Oral Presentation · No · Methods/Pharmacoepi
One Design to Rule Them All: The Clone-Censor-Weight Design as a General Framework for Epidemiologic Studies
Read more →2022 · Oral Presentation · Yes · Methods/Pharmacoepi
Negative Control Outcomes to Assess the Comparability of Biologics versus Small-molecule Therapeutics for Osteoporosis: Considerations for Differential Non-adherence
Read more →2022 · Oral Presentation · Yes · Methods/Pharmacoepi
The impact of parametric assumptions on the bias-variance tradeoff for causal analysis of time-to-event outcomes
Read more →2022 · Oral Presentation · University of North Carolina at Chapel Hill · Methods/Pharmacoepi
Fusion Designs for Indirect Treatment Effects
Read more →2022 · Oral Presentation · University of North Carolina at Chapel Hill · Methods/Pharmacoepi
On Teaching Advanced Epidemiologic Methods
Read more →2022 · Oral Presentation
Illustration of Two Fusion Designs and Estimators Get access Arrow
Read more →2022 · Oral Presentation · University of North Carolina at Chapel Hill · Methods/Pharmacoepi
Bridged treatment comparisons: an illustrative application in HIV treatment
Read more →2022 · Oral Presentation · Yes · Methods/Pharmacoepi
Disparities in Prevalence of Urinary Incontinence among a Nationally Representative Sample of Men, 2005-2016: Findings from the Urologic Diseases in America Project
Read more →2021 · Oral Presentation · No · Methods/Pharmacoepi
Use of negative control outcomes to detect mismeasured confounders in administrative data
Read more →2021 · Oral Presentation · University of California Los Angeles · Methods/Pharmacoepi
Fusion designs and estimators for treatment effects
Read more →2020 · Oral Presentation · No · Methods/Pharmacoepi
Real world treatment patterns following the initiation of proprotein convertase subtilisin/kexin type 9 antibody inhibitors among adults in the United States, 2015-2019
Read more →2020 · Oral Presentation · No · Methods/Pharmacoepi
History of lipid lowering therapy use among adults initiating treatment with proprotein convertase subtilisin/kexin type 9 antibody inhibitors in the United States, 2015-2019
Read more →2020 · Oral Presentation · University of North Carolina at Chapel Hill · Methods/Pharmacoepi
Estimating the Effect of Depression on HIV Transmission Risk Behaviors Among People Who Inject Drugs in Vietnam: A Causal Approach
Read more →2020 · Oral Presentation · University of North Carolina at Chapel Hill · Methods/Pharmacoepi
G-computation for policy-relevant effects of interventions on time-to-event outcomes
Read more →2019 · Oral Presentation · University of North Carolina at Chapel Hill · Methods/Pharmacoepi
Using Instrumental Variables to Address Bias from Unobserved Confounders
Read more →2019 · Oral Presentation · University of North Carolina at Chapel Hill · Methods/Pharmacoepi
Commentary: Compositional data call for complex interventions
Read more →2019 · Oral Presentation · University of North Carolina at Chapel Hill · Methods/Pharmacoepi
Using Bounds to Compare the Strength of Exchangeability Assumptions for Internal and External Validity
Read more →2019 · Oral Presentation · University of North Carolina at Chapel Hill · Methods/Pharmacoepi
Informative censoring by health plan disenrollment among commercially insured adults
Read more →2019 · Oral Presentation · University of North Carolina at Chapel Hill · Methods/Pharmacoepi
Nonparametric Bounds for the Risk Function
Read more →2018 · Oral Presentation · No · Methods/Pharmacoepi
Performance of machine learning algorithms for hysterectomy risk prediction among women with endometriosis in the United States
Read more →2018 · Oral Presentation · University of North Carolina at Chapel Hill · Methods/Pharmacoepi
Agreement between electronic health records and administrative claims data for patients with multiple myeloma
Read more →2018 · Oral Presentation · University of North Carolina at Chapel Hill · Methods/Pharmacoepi
A Practical Example Demonstrating the Utility of Single-world Intervention Graphs
Read more →2018 · Oral Presentation · University of North Carolina at Chapel Hill · Methods/Pharmacoepi
Using Negative Control Outcomes to Assess the Comparability of Osteoporosis Treatment Groups
Read more →
Contact us
By submitting this form, you consent to your information used by Headwater Science for the purpose of contacting you to better understand your potential interest in Headwater Science and/or its services. For more information, see our privacy policy.